These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Prognostic observation of chloroquine retinopathy]. Kikkawa T Ganka; 1971 Jul; 13(7):726-36. PubMed ID: 5105836 [No Abstract] [Full Text] [Related]
24. Drug-induced macular disease. Potts AM Trans Am Acad Ophthalmol Otolaryngol; 1966; 70(6):1054-7. PubMed ID: 5971468 [No Abstract] [Full Text] [Related]
25. [Routine monitoring of patients treated with synthetic antimalarials]. Douche C; Bechetoille A; Ebran JM J Fr Ophtalmol; 1983; 6(8-9):689-95. PubMed ID: 6677659 [TBL] [Abstract][Full Text] [Related]
26. Prolonged pharmacotherapy and the eye. A symposium. The antimalarials and the tranquilizers. Rubin M Dis Nerv Syst; 1968 Mar; 29(3):Suppl:67-76. PubMed ID: 4233735 [No Abstract] [Full Text] [Related]
27. [Changes in the electroretinogram during treatment with synthetic antimalarials]. Parizot H; Mawas E Bull Soc Ophtalmol Fr; 1965 Nov; 65(11):919-26. PubMed ID: 5866223 [No Abstract] [Full Text] [Related]
28. Chloroquine retinopathy: evaluation by fluorescein fundus angiography. Kearns TP; Hollenhorst RW Trans Am Ophthalmol Soc; 1966; 64():217-31. PubMed ID: 5964922 [No Abstract] [Full Text] [Related]
29. [Electroretinographic studies on the development of quinine and resochin retinopathies]. Jünemann G; Schulze J Klin Monbl Augenheilkd; 1968; 152(4):562-6. PubMed ID: 5686094 [No Abstract] [Full Text] [Related]
30. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB Retina; 2008; 28(10):1478-86. PubMed ID: 18997610 [TBL] [Abstract][Full Text] [Related]
31. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus. Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488 [No Abstract] [Full Text] [Related]
32. [Eye complications during treatment of bronchial asthma with antimalarials]. Ulanovová L; Benes J Cesk Oftalmol; 1968 Nov; 24(6):447-50. PubMed ID: 5701249 [No Abstract] [Full Text] [Related]
33. [Toxic effect of synthetic antimalarial drugs]. Wróblowa W Pol Tyg Lek; 1969 Aug; 24(31):1203-4. PubMed ID: 4898437 [No Abstract] [Full Text] [Related]
35. [Evaluation of a practical use of synthetic antimalarials in the treatment of rheumatoid polyarthritis]. David-Chaussé J; David-Chaussé F; Picot C; Laporte G; Lagoarde J; Dehais J Rev Rhum Mal Osteoartic; 1971 Nov; 38(11):681-90. PubMed ID: 5151168 [No Abstract] [Full Text] [Related]
36. THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS. KERSLEY GD Proc R Soc Med; 1964 Aug; 57(8):669-71. PubMed ID: 14195851 [No Abstract] [Full Text] [Related]
38. [Ocular changes caused by long-lasting use of chloroquine and its derivatives in rheumatoid disease]. Drewnowska-Sochańska A; Kuprianowicz W; Petrus B Klin Oczna; 1970; 40(4):499-503. PubMed ID: 5453064 [No Abstract] [Full Text] [Related]
39. [Several cases of retinal damage caused by synthetic antimalarials]. Ardouin M; Feuvrier YM; Tourtelier M Bull Soc Ophtalmol Fr; 1967 Sep; 67(9):803-9. PubMed ID: 5622176 [No Abstract] [Full Text] [Related]
40. [The cornea and synthetic antimalarials]. Jeddi A; Ben Osman N; Daghfous F; Bouguila H; Charfi O; Ayed S J Fr Ophtalmol; 1994; 17(1):36-8. PubMed ID: 8176172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]